Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. (CRXTQ) Stock Competitors & Peer Comparison
See (CRXTQ) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CRXTQ | $0.00 | +0.00% | 72.8K | -0.00 | -$0.47 | N/A |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.29% |
| RHHBF | $419.50 | +0.00% | 333.9B | 20.53 | $20.43 | +3.04% |
| RHHBY | $51.22 | -0.81% | 329.2B | 19.96 | $2.56 | +3.11% |
| RHHVF | $403.29 | +8.69% | 321B | 19.92 | $20.25 | +3.09% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $145.00 | -0.02% | 276.7B | 20.31 | $7.14 | +3.28% |
| SNYNF | $95.06 | +2.83% | 114.1B | 20.53 | $4.63 | +4.61% |
| GLAXF | $26.87 | -1.26% | 105.4B | 14.12 | $1.87 | +3.34% |
| CHGCF | $45.84 | -15.28% | 78.9B | 28.88 | $1.66 | +3.76% |
Stock Comparison
CRXTQ vs BMYMP Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, CRXTQ is priced at $0.00, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, CRXTQ's ROE is +0.33%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, CRXTQ is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check BMYMP's competition here
CRXTQ vs RHHBF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, RHHBF has a market cap of 333.9B. Regarding current trading prices, CRXTQ is priced at $0.00, while RHHBF trades at $419.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas RHHBF's P/E ratio is 20.53. In terms of profitability, CRXTQ's ROE is +0.33%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, CRXTQ is less volatile compared to RHHBF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check RHHBF's competition here
CRXTQ vs RHHBY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, RHHBY has a market cap of 329.2B. Regarding current trading prices, CRXTQ is priced at $0.00, while RHHBY trades at $51.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas RHHBY's P/E ratio is 19.96. In terms of profitability, CRXTQ's ROE is +0.33%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, CRXTQ is less volatile compared to RHHBY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check RHHBY's competition here
CRXTQ vs RHHVF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, CRXTQ is priced at $0.00, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas RHHVF's P/E ratio is 19.92. In terms of profitability, CRXTQ's ROE is +0.33%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, CRXTQ is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check RHHVF's competition here
CRXTQ vs AZNCF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, CRXTQ is priced at $0.00, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, CRXTQ's ROE is +0.33%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, CRXTQ is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check AZNCF's competition here
CRXTQ vs NVSEF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, NVSEF has a market cap of 276.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while NVSEF trades at $145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas NVSEF's P/E ratio is 20.31. In terms of profitability, CRXTQ's ROE is +0.33%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, CRXTQ is less volatile compared to NVSEF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check NVSEF's competition here
CRXTQ vs SNYNF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, SNYNF has a market cap of 114.1B. Regarding current trading prices, CRXTQ is priced at $0.00, while SNYNF trades at $95.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas SNYNF's P/E ratio is 20.53. In terms of profitability, CRXTQ's ROE is +0.33%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, CRXTQ and SNYNF have similar daily volatility (0.00).Check SNYNF's competition here
CRXTQ vs GLAXF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, GLAXF has a market cap of 105.4B. Regarding current trading prices, CRXTQ is priced at $0.00, while GLAXF trades at $26.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas GLAXF's P/E ratio is 14.12. In terms of profitability, CRXTQ's ROE is +0.33%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, CRXTQ is less volatile compared to GLAXF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check GLAXF's competition here
CRXTQ vs CHGCF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, CHGCF has a market cap of 78.9B. Regarding current trading prices, CRXTQ is priced at $0.00, while CHGCF trades at $45.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas CHGCF's P/E ratio is 28.88. In terms of profitability, CRXTQ's ROE is +0.33%, compared to CHGCF's ROE of +0.23%. Regarding short-term risk, CRXTQ is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check CHGCF's competition here
CRXTQ vs CHGCY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, CHGCY has a market cap of 76.5B. Regarding current trading prices, CRXTQ is priced at $0.00, while CHGCY trades at $23.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas CHGCY's P/E ratio is 27.99. In terms of profitability, CRXTQ's ROE is +0.33%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, CRXTQ is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check CHGCY's competition here
CRXTQ vs BAYRY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, BAYRY has a market cap of 43.9B. Regarding current trading prices, CRXTQ is priced at $0.00, while BAYRY trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas BAYRY's P/E ratio is -10.33. In terms of profitability, CRXTQ's ROE is +0.33%, compared to BAYRY's ROE of -0.12%. Regarding short-term risk, CRXTQ is less volatile compared to BAYRY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check BAYRY's competition here
CRXTQ vs OTSKY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, OTSKY has a market cap of 35B. Regarding current trading prices, CRXTQ is priced at $0.00, while OTSKY trades at $33.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas OTSKY's P/E ratio is 15.42. In terms of profitability, CRXTQ's ROE is +0.33%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, CRXTQ is less volatile compared to OTSKY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check OTSKY's competition here
CRXTQ vs OTSKF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, OTSKF has a market cap of 34.1B. Regarding current trading prices, CRXTQ is priced at $0.00, while OTSKF trades at $64.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas OTSKF's P/E ratio is 15.02. In terms of profitability, CRXTQ's ROE is +0.33%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, CRXTQ and OTSKF have similar daily volatility (0.00).Check OTSKF's competition here
CRXTQ vs DSKYF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, DSKYF has a market cap of 30.5B. Regarding current trading prices, CRXTQ is priced at $0.00, while DSKYF trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas DSKYF's P/E ratio is 17.53. In terms of profitability, CRXTQ's ROE is +0.33%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, CRXTQ is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check DSKYF's competition here
CRXTQ vs DSNKY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, DSNKY has a market cap of 30.1B. Regarding current trading prices, CRXTQ is priced at $0.00, while DSNKY trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas DSNKY's P/E ratio is 17.29. In terms of profitability, CRXTQ's ROE is +0.33%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, CRXTQ is less volatile compared to DSNKY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check DSNKY's competition here
CRXTQ vs ALPMF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, ALPMF has a market cap of 27.9B. Regarding current trading prices, CRXTQ is priced at $0.00, while ALPMF trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas ALPMF's P/E ratio is 35.45. In terms of profitability, CRXTQ's ROE is +0.33%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, CRXTQ is less volatile compared to ALPMF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check ALPMF's competition here
CRXTQ vs ALPMY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, ALPMY has a market cap of 27B. Regarding current trading prices, CRXTQ is priced at $0.00, while ALPMY trades at $15.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas ALPMY's P/E ratio is 34.20. In terms of profitability, CRXTQ's ROE is +0.33%, compared to ALPMY's ROE of +0.20%. Regarding short-term risk, CRXTQ is less volatile compared to ALPMY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check ALPMY's competition here
CRXTQ vs ORINY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, ORINY has a market cap of 22.3B. Regarding current trading prices, CRXTQ is priced at $0.00, while ORINY trades at $39.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas ORINY's P/E ratio is 18.01. In terms of profitability, CRXTQ's ROE is +0.33%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, CRXTQ and ORINY have similar daily volatility (0.00).Check ORINY's competition here
CRXTQ vs GIKLY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, GIKLY has a market cap of 15.1B. Regarding current trading prices, CRXTQ is priced at $0.00, while GIKLY trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas GIKLY's P/E ratio is 16.40. In terms of profitability, CRXTQ's ROE is +0.33%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, CRXTQ is less volatile compared to GIKLY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check GIKLY's competition here
CRXTQ vs CSPCY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, CSPCY has a market cap of 13.1B. Regarding current trading prices, CRXTQ is priced at $0.00, while CSPCY trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas CSPCY's P/E ratio is 22.60. In terms of profitability, CRXTQ's ROE is +0.33%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, CRXTQ is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check CSPCY's competition here
CRXTQ vs CHJTF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, CRXTQ is priced at $0.00, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, CRXTQ's ROE is +0.33%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, CRXTQ and CHJTF have similar daily volatility (0.00).Check CHJTF's competition here
CRXTQ vs ORINF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas ORINF's P/E ratio is 18.81. In terms of profitability, CRXTQ's ROE is +0.33%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, CRXTQ and ORINF have similar daily volatility (0.00).Check ORINF's competition here
CRXTQ vs RCDTF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, RCDTF has a market cap of 10B. Regarding current trading prices, CRXTQ is priced at $0.00, while RCDTF trades at $55.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas RCDTF's P/E ratio is 19.76. In terms of profitability, CRXTQ's ROE is +0.33%, compared to RCDTF's ROE of +0.23%. Regarding short-term risk, CRXTQ and RCDTF have similar daily volatility (0.00).Check RCDTF's competition here
CRXTQ vs GIFLF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, GIFLF has a market cap of 8.8B. Regarding current trading prices, CRXTQ is priced at $0.00, while GIFLF trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas GIFLF's P/E ratio is 18.70. In terms of profitability, CRXTQ's ROE is +0.33%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, CRXTQ and GIFLF have similar daily volatility (0.00).Check GIFLF's competition here
CRXTQ vs GIFOF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas GIFOF's P/E ratio is 12.83. In terms of profitability, CRXTQ's ROE is +0.33%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, CRXTQ and GIFOF have similar daily volatility (0.00).Check GIFOF's competition here
CRXTQ vs OPHLF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, CRXTQ is priced at $0.00, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas OPHLF's P/E ratio is 20.79. In terms of profitability, CRXTQ's ROE is +0.33%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, CRXTQ and OPHLF have similar daily volatility (0.00).Check OPHLF's competition here
CRXTQ vs OPHLY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, OPHLY has a market cap of 6.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while OPHLY trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas OPHLY's P/E ratio is 20.74. In terms of profitability, CRXTQ's ROE is +0.33%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, CRXTQ is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check OPHLY's competition here
CRXTQ vs KYKOF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, KYKOF has a market cap of 6.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while KYKOF trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas KYKOF's P/E ratio is 16.05. In terms of profitability, CRXTQ's ROE is +0.33%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CRXTQ and KYKOF have similar daily volatility (0.00).Check KYKOF's competition here
CRXTQ vs DPHAY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CRXTQ is priced at $0.00, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CRXTQ's ROE is +0.33%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CRXTQ and DPHAY have similar daily volatility (0.00).Check DPHAY's competition here
CRXTQ vs VRBCF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, VRBCF has a market cap of 3.6B. Regarding current trading prices, CRXTQ is priced at $0.00, while VRBCF trades at $431.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas VRBCF's P/E ratio is 20.37. In terms of profitability, CRXTQ's ROE is +0.33%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CRXTQ and VRBCF have similar daily volatility (0.00).Check VRBCF's competition here
CRXTQ vs SNPHF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, CRXTQ is priced at $0.00, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas SNPHF's P/E ratio is 18.95. In terms of profitability, CRXTQ's ROE is +0.33%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, CRXTQ and SNPHF have similar daily volatility (0.00).Check SNPHF's competition here
CRXTQ vs SNPHY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, SNPHY has a market cap of 3.3B. Regarding current trading prices, CRXTQ is priced at $0.00, while SNPHY trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas SNPHY's P/E ratio is 17.74. In terms of profitability, CRXTQ's ROE is +0.33%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, CRXTQ is less volatile compared to SNPHY. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check SNPHY's competition here
CRXTQ vs HAWPY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, CRXTQ is priced at $0.00, while HAWPY trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas HAWPY's P/E ratio is 14.48. In terms of profitability, CRXTQ's ROE is +0.33%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CRXTQ and HAWPY have similar daily volatility (0.00).Check HAWPY's competition here
CRXTQ vs PTKFF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, PTKFF has a market cap of 2.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while PTKFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CRXTQ's ROE is +0.33%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, CRXTQ and PTKFF have similar daily volatility (0.00).Check PTKFF's competition here
CRXTQ vs HAWPF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, CRXTQ is priced at $0.00, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, CRXTQ's ROE is +0.33%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CRXTQ is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check HAWPF's competition here
CRXTQ vs CMOPF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, CMOPF has a market cap of 1.9B. Regarding current trading prices, CRXTQ is priced at $0.00, while CMOPF trades at $118.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas CMOPF's P/E ratio is -455.77. In terms of profitability, CRXTQ's ROE is +0.33%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, CRXTQ is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check CMOPF's competition here
CRXTQ vs LYPHF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, LYPHF has a market cap of 1.6B. Regarding current trading prices, CRXTQ is priced at $0.00, while LYPHF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas LYPHF's P/E ratio is 19.75. In terms of profitability, CRXTQ's ROE is +0.33%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, CRXTQ is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check LYPHF's competition here
CRXTQ vs TGRNF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, CRXTQ is priced at $0.00, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, CRXTQ's ROE is +0.33%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, CRXTQ and TGRNF have similar daily volatility (0.00).Check TGRNF's competition here
CRXTQ vs JCRRF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, JCRRF has a market cap of 518.4M. Regarding current trading prices, CRXTQ is priced at $0.00, while JCRRF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas JCRRF's P/E ratio is -35.42. In terms of profitability, CRXTQ's ROE is +0.33%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, CRXTQ and JCRRF have similar daily volatility (0.00).Check JCRRF's competition here
CRXTQ vs MAYNF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, MAYNF has a market cap of 143M. Regarding current trading prices, CRXTQ is priced at $0.00, while MAYNF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas MAYNF's P/E ratio is -2.35. In terms of profitability, CRXTQ's ROE is +0.33%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, CRXTQ and MAYNF have similar daily volatility (0.00).Check MAYNF's competition here
CRXTQ vs PTKFY Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, PTKFY has a market cap of 11.6M. Regarding current trading prices, CRXTQ is priced at $0.00, while PTKFY trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas PTKFY's P/E ratio is 11.02. In terms of profitability, CRXTQ's ROE is +0.33%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, CRXTQ and PTKFY have similar daily volatility (0.00).Check PTKFY's competition here
CRXTQ vs PSYGF Comparison April 2026
CRXTQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRXTQ stands at 72.8K. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, CRXTQ is priced at $0.00, while PSYGF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRXTQ currently has a P/E ratio of -0.00, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, CRXTQ's ROE is +0.33%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, CRXTQ is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CRXTQ.Check PSYGF's competition here